𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: Necessity for prospective randomized trial

✍ Scribed by Fuyo Yoshimi; Takeshi Nagao; Sumio Inoue; Nobuhiro Kawano; Tetsuichiro Muto; Toshiaki Gunji; Shin Ohnishi; Michio Imawari


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
482 KB
Volume
16
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Transcatheter arterial chemoembolization is now widely used in cases of surgically unresectable hepatocellular carcinoma. However, it is unclear whether patients with surgically resectable hepatocellular carcinoma should always be treated with hepatectomy as opposed to transcatheter arterial chemoembolization. Sixty-six patients with hepatocellular carcinoma underwent hepatectomy, whereas 29 patients with more advanced hepatocellular carcinoma were treated with transcatheter arterial chemoembolization at our hospital from 1984 to 1990. All cases were associated with cirrhosis of Child class A or B. AU of them underwent hepatectomy or transcatheter arterial chemoembolization for the first time. Their outcomes were determined on March 31, 1991. The backgrounds and survival curves for hepatectomy and transcatheter arterial chemoembolization were compared in both Child A and Child B patients. For both Child A and B patients, no significant difference was found between hepatectomy and transcatheter arterial chemoembolization with respect to age, sex, cause of underlying cirrhosis, liver function assessed by indocyanine green test and maximum diameter of the main tumor. The incidence of multiple hepatocellular carcinoma, more advanced hepatocellular carcinoma (TNM stage III or IV) or both was significantly higher in the transcatheter arterial chemoembolization group than in the hepatectomy group for both Child A and Child B patients. The survival curves of both the hepatectomy and the transcatheter arterial chemoembolization groups showed no significant difference for both Child A and Child B patients. A prospective study is therefore warranted to elucidate whether hepatectomy or transcatheter arterial chemoembolization is more effective for treating resectable hepatocellular carcinoma 8580- ciated with cirrhosis. (HEPATOLOGY 1992; 16702-706.)

Recent advances in imaging techniques and surgical instruments have improved the safety of hepatectomy in patients who have HCC with underlying cirrhosis. Hepatectomy is now being performed in many centers


πŸ“œ SIMILAR VOLUMES


Prospective randomized trial of chemoemb
✍ J Raoul; D Guyader; J Bretagne; J Heautot; R Duvauferrier; P Bourguet; D Bekhech πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 191 KB πŸ‘ 1 views

Intra-arterial injection of radioactive Lipiodol has shown promising results in patients with hepatocellular carcinoma (HCC) and portal obstruction. The aim of this prospective, randomized trial was to compare the efficacy and tolerance of 131I-labeled Lipiodol and chemoembolization for the treatmen

Randomized controlled trial of interfero
✍ Josep M. Llovet; Margarita Sala; LluΓ­s Castells; Yanette Suarez; Ramon Vilana; L πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 2 views

The aim of this randomized controlled trial was to assess the efficacy of interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma (HCC). Fifty-eight patients with HCC who were not suitable for resection, transplantation, ethanol injection, or arterial embolization were strati

The safety and efficacy of transcatheter
✍ Hyo-Suk Lee; Joo Sung Kim; Il Ju Choi; Jin Wook Chung; Jae Hyung Park; Chung Yon πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 3 views

## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co